Protagonist Therapeutics (PTGX) Total Debt (2018 - 2023)
Protagonist Therapeutics (PTGX) posted Total Debt of $10000.0 for Q2 2023, down 54.55% sequentially from $22000.0 in Q1 2023, and down 87.5% YoY from $80000.0 in Q2 2022.
Protagonist Therapeutics (PTGX) Total Debt (2018 - 2023) Analysis & Trends
Protagonist Therapeutics has reported Total Debt for 6 years, with the latest figure at $10000.0 in Q2 2023.
- Quarterly Total Debt fell 87.5% year-over-year to $10000.0 in Q2 2023, while the trailing twelve-month figure through Jun 2023 was $10000.0 (down 87.5% YoY) and the FY2022 annual result came in at $69000.0, down 92.32% from the prior year.
- Total Debt fell to $10000.0 in Q2 2023 per PTGX's latest filing, from $22000.0 in the prior quarter.
- Over five years, Total Debt peaked at $11.4 million in Q2 2021 and troughed at $10000.0 in Q2 2023.
- A 5-year average of $2.9 million and a median of $1.0 million in 2019 frame the typical range for Total Debt.
- The sharpest annual moves came in 2021 and 2022: Total Debt soared 1036.19% in 2021, then plunged 99.3% in 2022.
- Over 5 years, Total Debt stood at $11.1 million in 2019, then slumped by 75.29% to $2.7 million in 2020, then sank by 67.09% to $899000.0 in 2021, then slumped by 92.32% to $69000.0 in 2022, then plunged by 85.51% to $10000.0 in 2023.
- According to Business Quant data, Total Debt over the past three periods registered $10000.0, $22000.0, and $69000.0 for Q2 2023, Q1 2023, and Q4 2022 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.07 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 9.34 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 546.77 Mn |
| 10 | Protagonist Therapeutics | 10.03 Bn | 10.03 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 10,000.00 |
| Mar 31, 2023 | 22,000.00 |
| Dec 31, 2022 | 69,000.00 |
| Sep 30, 2022 | 32,000.00 |
| Jun 30, 2022 | 80,000.00 |
| Mar 31, 2022 | 380,000.00 |
| Dec 31, 2021 | 899,000.00 |
| Sep 30, 2021 | 1.12 Mn |
| Jun 30, 2021 | 11.40 Mn |
| Mar 31, 2021 | 6.82 Mn |
| Dec 31, 2020 | 2.73 Mn |
| Sep 30, 2020 | 2.08 Mn |
| Jun 30, 2020 | 1.00 Mn |
| Mar 31, 2020 | 10.95 Mn |
| Dec 31, 2019 | 11.06 Mn |
| Sep 30, 2019 | 1.02 Mn |
| Jun 30, 2019 | 810,000.00 |
| Mar 31, 2019 | 1.21 Mn |
| Dec 31, 2018 | 1.06 Mn |
| Sep 30, 2018 | 764,000.00 |